|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0007226,
umls-concept:C0015127,
umls-concept:C0026565,
umls-concept:C0038952,
umls-concept:C0039286,
umls-concept:C0332189,
umls-concept:C0441471,
umls-concept:C0441988,
umls-concept:C0476089,
umls-concept:C0936012,
umls-concept:C1314792,
umls-concept:C1516231,
umls-concept:C1522673
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-7-1
|
|
pubmed:abstractText |
This study provides estimates of the effect of tamoxifen treatment on mortality from four conditions known to be affected by tamoxifen in women who survive their breast cancer: contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic events. These estimates are in addition to tamoxifen's impact on primary breast cancer mortality.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2018-24
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9626198-Aged,
pubmed-meshheading:9626198-Aged, 80 and over,
pubmed-meshheading:9626198-Breast Neoplasms,
pubmed-meshheading:9626198-Cardiovascular Diseases,
pubmed-meshheading:9626198-Endometrial Neoplasms,
pubmed-meshheading:9626198-Female,
pubmed-meshheading:9626198-Follow-Up Studies,
pubmed-meshheading:9626198-Humans,
pubmed-meshheading:9626198-Middle Aged,
pubmed-meshheading:9626198-Neoplasms, Second Primary,
pubmed-meshheading:9626198-Risk,
pubmed-meshheading:9626198-Survival Rate,
pubmed-meshheading:9626198-Tamoxifen,
pubmed-meshheading:9626198-Thromboembolism,
pubmed-meshheading:9626198-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.
|
|
pubmed:affiliation |
Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. jragaz@bccancer.bc.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
